Biological Oxidation of Nitrogen in Organic Compounds and Disposition of N-Oxidized Product

References

• Wright A., Beckett H., Al-Sarraj S. The mechanism of oxidation of amphetamine enantiomorphs by liver microsomal preparations from different specie. J. Pharm. Pharmacol. 1972; 24: 174
   PubMed Web of Science ®Google Scholar
• Cho J.A. K., Gal J. The metabolism of amphetamine in vitro by rabbit liver preparation. Xenobiotica 1977; 7: 257
   PubMedGoogle Scholar
• Beckett A. H., Chidomere E. C. The identification and analysis of mexiletine and its metabolic products in ma. J. Pharm. Pharmacol. 1977; 29: 281
   PubMed Web of Science ®Google Scholar
• Cho A., Lindeke K.B., Sum C. Y. The N-hydroxylation of phentermin. Drug Metab. Dispos. 1974; 2: 1
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Bélanger P. M. The microsomal N-oxidation of phentermin. J. Pharm. Pharmacol. 1976; 28: 692
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Bélanger P. M. The disposition of phentermine and its N-oxidized metabolic products in the rabbi. Xenobiotica 1978; 8: 55
   PubMed Web of Science ®Google Scholar
• Sum C. Y., Cho A. K. The N-hydroxylation of phentermine by rat liver microsome. Drug Metab. Dispos. 1977; 5: 464
   PubMed Web of Science ®Google Scholar
• Hlavica P., Kiese M. N-Oxygenation of N-alkyl-and N.N-dialkylanilines by rabbit liver microsome. Biochem. Pharmacol. 1969; 18: 1501
   PubMed Web of Science ®Google Scholar
• Heinze Hlavica E., Kiese P.M., Lipowsky G. N-Oxygenation of arylamines in microsomes prepared from corpora lutea of the cycle and other tissues of the pi. Biochem. Pharmacol. 1970; 19: 641
   PubMed Web of Science ®Google Scholar
• Hlavica P. Studies on the active site of mixed function oxidases in rabbit liver microsome. Biochem. Biophys. Res. Commun. 1970; 40: 212
   PubMed Web of Science ®Google Scholar
• Hlavica P. Hepatic mixed function amine oxidase: An allosteric syste. Xenobiotica 1971; 1: 537
   PubMedGoogle Scholar
• Hlavica P. Interaction of oxygen and aromatic amines with hepatic microsomal mixed function oxidas. Biochim. Biophys. Acta. 1972; 273: 318
   PubMed Web of Science ®Google Scholar
• Hlavica P., Kehl M. Studies on the mechanism of hepatic microsomal N-oxide formation, I. Effect of carbon monoxide on the N-oxidation of N.N-dimethylanilin. Hoppe-Seyler's Z. Physiol. Chem. 1974; 355: 1508
   PubMedGoogle Scholar
• Hlavica P., Kehl M. Comparative studies on the N-oxidation of aniline and N.N-dimethylaniline by rabbit liver microsome. Xenobiotica 1976; 6: 679
   PubMed Web of Science ®Google Scholar
• Thauer R. K., Stöffler G., Uehleke H. N-Hydroxylierung von Sulfanilamid zu p-Hydroxyaminobenzoesulfonamid durch Lebermikrosome. Naunyn-Schmiedeberg's Arch. Exp. Pathol Pharmakol. 1965; 252: 32
   PubMedGoogle Scholar
• Uehleke H., Nestle K. Hydroxylamino- und Nitrosobiphenyl: Biologische Oxidationsprodukte von 4-Aminobiphenyl und Zwischenprodukte der Reduktion von 4-Nitrobipheny. Naunyn-Schmiedeberg's Arch. Pharmakol. Exp. Pathol. 1967; 257: 151
   Google Scholar
• Uehleke H. N-Hydroxylierung von p-Phenetidin in vivo und durch isolierte Mikrosomen aus Lebern und Nieren: Stimmulierung durch Phenobarbital-Vorbehandlun. Naunyn-Schmiedeberg's Arch. Pharmakol. 1969; 264: 434
   PubMedGoogle Scholar
• Uehleke H., Schnitger F., Hellmer K. H. Verhalten verschiedener mikrosomaler Fremdstoff-oxidationen nach Inaktivierung von Cytochrom P-450 durch UV-Bestrahlung oder durch Deoxycholatbehandlun. Hoppe-Seyler's Z. Physiol. Chem. 1970; 351: 1475
   PubMedGoogle Scholar
• Uehleke H. N-Hydroxylatio. Xenobiotica 1971; 1: 327
   PubMedGoogle Scholar
• Uehleke H., Hellmer K. H. Competitive inhibition of the microsomal N-hydroxylation of 4-chloroaniline by metyrapone and cyclohexan. Naunyn-Schmiedeberg's Arch. Pharmakol. 1971; 268: 242
   PubMedGoogle Scholar
• Uehleke H., Tabarelli S. N-Hydroxylation of 4,4′-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and human. Naunyn-Schmiedeberg's Arch. Pharmacol. 1973; 278: 55
   Google Scholar
• Uehleke H. The role of cytochrome P-450 in the N-oxidation of individual amine. Drug. Metab. Dispos. 1973; 1: 299
   PubMed Web of Science ®Google Scholar
• Schmidt H., Kexel L.H., Weber N. Mikrosomale Oxydationen am Stickstoffatom aromatischer Amin. Biochem. Pharmacol. 1972; 21: 1641
   PubMed Web of Science ®Google Scholar
• Smith M. R., Gorrod J. W. The microsomal N-oxidation of some primary aromatic amine. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevier, Amsterdam 1978; 65
   Google Scholar
• Poulsen L., Masters L.B. S. S., Ziegler D. M. Mechanism of 2-naphthylamine oxidation catalysed by pig liver microsome. Xenobiotica 1976; 6: 481
   PubMed Web of Science ®Google Scholar
• Boyland E., Nery R. The metabolism of urethane and related compound. Biochem. J. 1965; 94: 198
   PubMed Web of Science ®Google Scholar
• Nery R. Some aspects of the metabolism of urethane and N-hydroxyurethane in rodent. Biochem. J. 1968; 106: 1
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Haya K. The identification and quantification of the major metabolites of ethylamphetamine, produced by rabbit liver microsomal preparation. J. Pharm. Pharmacol. 1977; 29: 89
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Gibson G. G. Identification of the in vitro N-oxidized metabolites of (+)- and (-)-N-benzylamphetamin. J. Pharm. Pharmacol. 1977; 29: 756
   PubMed Web of Science ®Google Scholar
• Coutts R. T., Kovach S. H. Metabolism in vitro of N-methylamphetamine with rat liver homogenate. Biochem. Pharmacol. 1977; 26: 1043
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Al-Sarrj. S. N-Oxidation of primary and secondary amines to give hydroxylamines—a general metabolic rout. J. Pharm. Pharmacol. 1972; 24: 916
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Rahman N. N. Metabolic products of N-ethyl-β-methoxy-β-(3′-trifluoromethylphenyl) ethylamine (SKF 40652-A. Xenobiotica 1977; 7: 537
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Gibson G. G. Microsomal N-hydroxylation of dibenzylamin. Xenobiotica 1975; 5: 677
   PubMed Web of Science ®Google Scholar
• Phillipson J., El-Dabbas D.S. W., Gorrod J. W. Metabolism of morphine and codeine by guinea-pig liver microsomal preparations and by rat. Eur. J. Drug Metab. Pharmacokinet. 1978; 3: 119
   Google Scholar
• Gorrod J. W., Temple D. J. The formation of an N-hydroxymethyl intermediate in the N-demethylation of N-methylcarbazole in vivo and in vitr. Xenobiotica 1976; 6: 265
   PubMed Web of Science ®Google Scholar
• Phillipson J., Handa D.S. S., Gorrod J. W. Metabolic N-oxidation of atropine, hyoscine and the corresponding noralkaloids by guinea-pig liver microsomal preparation. J. Pharm. Pharmacol. 1976; 28: 687
   PubMedGoogle Scholar
• Beckett A. H., Salami M. A. A note on the identification of N-hydroxyphenmetrazine as a metabolic product of phendimetrazine and phenmetrazin. J. Pharm. Pharmacol. 1972; 24: 900
   PubMed Web of Science ®Google Scholar
• Jaccarini A., Felice M. A. The metabolism of pyrroles and indoles: ring nitrogen oxidatio. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevier, Amsterdam 1978; 169
   Google Scholar
• Lotlikar P., Luha D.L., Zaleski K. Reconstituted hamster liver microsomal enzyme system for N-dyroxylation of the carcinogen 2-acetylaminofluoren. Biochem. Biophys. Res. Commun. 1974; 59: 1349
   PubMedGoogle Scholar
• Lotlikar P. D., Zaleski K. Inhibitory effect of carbon monoxide on the N-and ring-hydroxylation of 2-acetamidofluorene by hamster hepatic microsomal preparation. Biochem. J. 1974; 144: 427
   PubMed Web of Science ®Google Scholar
• Lotlikar P. D., Zaleski K. Ring and N-hydroxylation of 2-acetamidofluorene by rat liver reconstituted cytochrome P-450 enzyme syste. Biochem. J. 1975; 150: 561
   PubMed Web of Science ®Google Scholar
• Lotlikar P. D., Dwyer E. N. Effect of detergents on the N-and ring-hydroxylation of 2-acetamidofluorene by hamster liver microsomal preparation. Biochem. J. 1976; 160: 821
   PubMed Web of Science ®Google Scholar
• Lotlikar P., Dwyer D., Baldy E. N.W. J., Nyce J. Phospholipid requirement for 2-acetamidofluorene N-and ring-hydroxylation by hamster liver microsomal cytochrome P-450 enzyme syste. Biochem. J. 1977; 168: 571
   PubMed Web of Science ®Google Scholar
• Matsushima T., Weisburger J. H. Effect of carbon monoxide or of 3-aminotriazole on C- and N-hydroxylation of the carcinogen N-2-fluorenylacetamide by liver microsomes of hamsters pretreated with 3-methylcholanthren. Xenobiotica 1972; 2: 423
   PubMed Web of Science ®Google Scholar
• Thorgeirsson S., Jollow S., Sasame D. J., Green H. A.A., Mitchell J. R. The role of cytochrome P-450 in N-hydroxylation of 2-acetylaminofluoren. Mol. Pharmacol. 1973; 9: 398
   PubMed Web of Science ®Google Scholar
• Thorgeirsson S., Felton S.J. S., Nebert D. W. Genetic differences in the aromatic hydrocarbon-inducible N-hydroxylation of 2-acetylaminofluorene and acetaminophen-produced hepatotoxicity in mic. Mol. Pharmacol. 1975; 11: 159
   PubMed Web of Science ®Google Scholar
• Gutmann H. R., Bell P. N-Hydroxylation of arylamides by the rat and guinea pi. Biochim. Biophys. Acta 1977; 498: 229
   PubMed Web of Science ®Google Scholar
• Gammans R., Sehon E., Anders R. D.M. W., Hanna P. E. Microsomal N-hydroxylation of trans-4′-halo-4-acetamidostilbene. Drug Metab. Dispos. 1977; 5: 310
   PubMed Web of Science ®Google Scholar
• Hinson J., Mitchell A.J. R., Jollow D. J. Microsomal N-hydroxylation of p-chloroacetanilid. Mol. Pharmacol. 1975; 11: 462
   Web of Science ®Google Scholar
• Hinson J. A., Mitchell J. R. N-Hydroxylation of phenacetin by hamster liver microsome. Drug Metab. Dispos. 1976; 4: 430
   PubMed Web of Science ®Google Scholar
• Hucker H., Balletto B., Demetriades A. J., Arison J.B. H., Zacchei A. G. Urinary metabolites of amitriptyline in the do. Drug. Metab. Dispos. 1977; 5: 132
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Hewick D. S. The N-oxidation of chlorpromazine in vitro - the major metabolic route using rat liver microsome. J. Pharm. Pharmacol. 1967; 19: 134
   Web of Science ®Google Scholar
• Jenner P. The role of nitrogen oxidation in the excretion of drugs and foreign compound. Xenobiotica 1971; 1: 399
   PubMedGoogle Scholar
• Drach J. C., Howell J. P. Identification of diphenhydramine urinary metabolites in the rhesus monke. Biochem. Pharmacol. 1968; 17: 2125
   PubMed Web of Science ®Google Scholar
• Nakazawa K. Studies on the demethylation, hydroxylation and N-oxidation of imipramine in the ra. Biochem. Pharmacol. 1970; 19: 1363
   PubMed Web of Science ®Google Scholar
• Gigon P. L., Bickel M. H. N-Demethylation and N-oxidation of imipramine by rat and pig liver microsome. Biochem. Pharmacol. 1971; 20: 1921
   PubMed Web of Science ®Google Scholar
• Davis C. M., Fenimore D. C. Methadone N-oxide in the rhesus monke. J. Pharm. Pharmacol. 1977; 29: 573
   PubMed Web of Science ®Google Scholar
• Baker J. R., Chaykin S. The biosynthesis of trimethylamine N-oxid. J. Biol Chem. 1962; 237: 1309
   PubMed Web of Science ®Google Scholar
• Oelschläger H., Temple D. J. The role of N-oxidation in the metabolism of morpholine containing drug. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevier, Amsterdam 1978; 71
   Google Scholar
• Testa Jenner B., Beckett P.A. H., Gorrod J. W. A reappraisal of the stereoselective metabolism of nicotine to nicotine-l'-N-oxid. Xenobiotica 1976; 6: 553
   PubMed Web of Science ®Google Scholar
• White I. N. H., Mattocks A. R. Some factors affecting the conversion of pyrrolizidine alkaloids to the N-oxides and to pyrrolic derivative. in vitro, Xenobiotica 1971; 1: 503
   PubMedGoogle Scholar
• Gorrod J. W., Damani L. A. The effect of various potential inhibitors, activators and inducers on the N-oxidation of 3-substituted pyridine. in vitro Xenobiotica 1979; 9: 219
   PubMed Web of Science ®Google Scholar
• De Graeve Gielen J., Kahl J. E.G. F., Tüttenberg K., Kahl H.R., Maume B. Formation of two metyrapone N-oxides by rat liver microsome. Drug Metab. Dispos. 1979; 7: 166
   PubMed Web of Science ®Google Scholar
• Schwartz M., Williams A., Kolis T. H., Postma S. J.E., Sasso G. J. Biotransformation of prochiral 2-phenyl-1,3-di (4-pyridyl)-2-propanol to a chiral N-oxide metabolit. Drug Metab. Dispos. 1978; 6: 647
   PubMed Web of Science ®Google Scholar
• Hubbell J., Henning P., Grace M. L., Nichol M. E.C. A., Sigel C. W. N-Oxide metabolites of the 2,4-diaminopyrimidine inhibitors of dihydrofolate reductase, trimethoprim, pyrimethamine and metoprin. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevier, Amsterdam 1978; 177
   Google Scholar
• Gorrod J. W. The biological oxidation of aromatic heterocyclic amine. Xenobiotica 1971; 1: 349
   PubMedGoogle Scholar
• Casida J. E., Stahmann M. A. Metabolism and mode of action of Schrada. J. Agric. Food Chem. 1953; 1: 883
   Web of Science ®Google Scholar
• Parli C., Wang J.N., McMahon R. E. The enzymatic N-hydroxylation of an imin. J. Biol Chem. 1971; 246: 6953
   PubMed Web of Science ®Google Scholar
• Prough R., Coomes A.M. L., Dunn D. L. The microsomal metabolism of carcinogenic and/or therapeutic hydrazine. Microsomes and Drug Oxidations, V. Ullrich. Pergamon Pres, Oxford 1977; 500
   Google Scholar
• Beckett A., Purkaystha H.A. R., Morgan P. H. Oxidation of aliphatic hydroxylamines in aqueous solution. J. Pharm. Pharmacol. 1977; 29: 15
   PubMed Web of Science ®Google Scholar
• Jonsson Lundkvist U., Bergstrand G., Eriksson B.S. O., Lindeke B. Autoxidation of N-hydroxyphenylalkylamine. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevier, Amsterdam 1978; 275
   Google Scholar
• Jonsson Lundkvist U., Eriksson G.S. O., Lindeke B. Autoxidation of N-hydroxyphenylakylamines: the inhibitory effect of some anions on copper catalysed autoxidation of N-hydroxyphentermin. J. Pharm. Pharmacol. 1977; 29: 358
   PubMed Web of Science ®Google Scholar
• Das M. L., Ziegler D. M. Rat liver oxidative N-dealkylase and N-oxidase activities as a function of animal ag. Arch. Biochem. Biophys. 1970; 140: 300
   PubMed Web of Science ®Google Scholar
• Booth J., Boyland E. The biochemistry of aromatic amine. Biochem. J. 1964; 91: 362
   PubMed Web of Science ®Google Scholar
• Jagow R., Kiese M. Isolation of N-hydroxy-p-aminopropiophenone from the urine of rabbits injected with p-aminopropiophenon. Biochim. Biophys. Acta 1967; 136: 168
   PubMed Web of Science ®Google Scholar
• Jagow R., Kiese M., Renner G. Urinary excretion of N-hydroxy derivatives of some aromatic amines by rabbits, guinea pigs, and dog. Biochem. Pharmacol. 1966; 15: 1899
   PubMed Web of Science ®Google Scholar
• Uehleke H., Brill E. Increased metabolic N-oxidation of 2-naphthylamine in dogs after phenobarbital pretreatmen. Biochem. Pharmacol. 1968; 17: 1459
   PubMed Web of Science ®Google Scholar
• Prough R. A., Ziegler D. M. The relative participation of liver microsomal amine oxidase and cytochrome P-450 in N-demethylation reaction. Arch. Biochem. Biophys. 1977; 180: 363
   PubMed Web of Science ®Google Scholar
• Utzinger G. E., Regenass F. A. N-Alkyl-arylhydroxylamin. Helv. Chim. Acta 1954; 37: 1885
   Google Scholar
• Ochiai E. Aromatic amine oxides. Elsevier, Amsterdam 1967
   Google Scholar
• Gorrod J. W., Damani L. A. Direct gas-liquid chromatographic analysis of some pyridine-N-oxide. J. Chromatogr. 1978; 155: 349
   Web of Science ®Google Scholar
• Kiese M., Rauscher E. The failure of some aromatic amines to produce hemiglobin in vivo in spite of microsomal N-hydroxylatio. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. 1965; 251: 201
   PubMedGoogle Scholar
• Kampffmeyer H., Kiese M. Further factors affecting the hydroxylation of aniline and some of its derivatives by liver microsome. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. 1964; 246: 397
   PubMedGoogle Scholar
• Kiese M., Uehleke H. Der Ort der N-Oxydation des Anilins im höheren Tie. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. 1961; 242: 117
   Google Scholar
• Patterson L. H., Gorrod J. W. The metabolism of some 4-substituted-N-ethyl-N-methylaniline-N-oxide. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevier, Amsterdam 1978; 471
   Google Scholar
• Gorrod J., Temple W.D. J., Beckett A. H. The N- and α-C-oxidation of N. N-dialkylanilines by rabbit liver microsomes in vitr. Xenobiotica 1979; 9: 17
   PubMed Web of Science ®Google Scholar
• Gorrod J. W., Damani L. A. Some factors involved in the N-oxidation of 3-substituted pyridines by microsomal preparation. in vitro, Xenobiotica 1979; 9: 209
   PubMed Web of Science ®Google Scholar
• Beckett A., Mitchard H.M., Shihab A. A. The influence of methyl substitution on the N-demethylation and N-oxidation of normethadone in animal specie. J. Pharm. Pharmacol. 1971; 23: 941
   PubMed Web of Science ®Google Scholar
• Irving C. C. Enzymatic N-hydroxylation of the carcinogen 2-acetylaminofluorene and the metabolism of N-hydroxy-2-acetylaminofluorene-9-14. in vitro, J. Biol. Chem. 1964; 239: 1589
   PubMed Web of Science ®Google Scholar
• Prough R. A. The N-oxidation of alkylhydrazines catalysed by the microsomal mixed-function amine oxidas. Arch. Biochem. Biophys. 1973; 158: 442
   PubMed Web of Science ®Google Scholar
• Beckett A. H. Metabolic oxidation of aliphatic basic nitrogen atoms and their α-carbon atom. Xenobiotica 1971; 1: 365
   PubMedGoogle Scholar
• Herr F, Kiese M. Bestimmung von Nitrosobenzol im Blut. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. 1959; 235: 351
   PubMedGoogle Scholar
• Ziegler D. M., Pettit F. H. Formation of an intermediate N-oxide in the oxidative demethylation of N.N-dimethylaniline catalysed by liver microsome. Biochem. Biophys. Res. Commun. 1964; 15: 188
   PubMed Web of Science ®Google Scholar
• Fok A. K., Ziegler D. M. Estimation of amine oxides in the presence of hepatic microsome. Biochem. Biophys. Res. Commun. 1970; 41: 534
   PubMed Web of Science ®Google Scholar
• Mattocks A. R., White I. N. H. Estimation of metabolites of pyrrolizidine alkaloids in animal tissue. Anal. Biochem. 1970; 38: 529
   PubMed Web of Science ®Google Scholar
• Kiese M., Renner G. The isolation of p-chloronitrosobenzene from the blood of dogs injected with p-chloroanilin. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. 1963; 246: 163
   PubMedGoogle Scholar
• Andersen R., Enomoto A., Miller M.E. C., Miller J. A. Carcinogenesis and inhibition of the Walker 256 tumor in the rat by trans-4-acetylaminostilbene, its N-hydroxy metabolite, and related compound. Cancer Res. 1964; 24: 128
   PubMed Web of Science ®Google Scholar
• Miller E., Lotlikar C., Pitot P. D., Fletcher H. C.T. L., Miller J. A. N-Hydroxy metabolites of 2-acetylaminophenanthrene and 7-fluoro-2-acetylaminofluorene as proximate carcinogens in the ra. Cancer Res. 1966; 26: 2239
   PubMed Web of Science ®Google Scholar
• Baker J., Struempler R.A., Chaykin S. A comparative study of trimethylamine-N-oxide biosynthesi. Biochim. Biophys. Acta 1963; 71: 58
   PubMed Web of Science ®Google Scholar
• Jenner P.J., Gorrod W., Beckett A. H. Factors affecting the in vitro metabolism of R-(+)-and S-(-)- nicotine by guinea pig liver preparation. Xenobiotica 1973; 3: 563
   PubMed Web of Science ®Google Scholar
• Chaykin Dagani S., Johnson M.L., Samli M. The fate of nicotinamide in the mous. J. Biol. Chem. 1965; 240: 932
   PubMed Web of Science ®Google Scholar
• Sullivan P., Kester T.M., Norton S. J. Synthesis and study of pyridylalanine-N-oxide. J. Med. Chem. 1968; 11: 1172
   PubMed Web of Science ®Google Scholar
• Patterson L., Damani H., Smith L. A.M. R., Gorrod J. W. Use of chromatographic techniques for the detection and quantitation of N-oxygenated metabolite. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevier, Amsterdam 1978; 213
   Google Scholar
• Bickel M. H. Liver metabolic reactions: tertiary amine N-dealkylation, tertiary amine N-oxidation, N-oxide reduction, and N-oxide N-dealkylatio. Arch. Biochem. Biophys. 1971; 148: 54
   Web of Science ®Google Scholar
• Harinath B. C., Odell G. V. Chlorpromazine-N-oxide formation by subcellular liver fraction. Biochem. Pharmacol. 1968; 17: 167
   PubMed Web of Science ®Google Scholar
• Bickel M. H., Gigon P. L. Metabolic interconversions and binding of imipramine, imipramine-N-oxide, and desmethylimipramine in rat liver slice. Xenobiotica 1971; 1: 631
   PubMedGoogle Scholar
• Uehleke Breyer H., Budczies U., Tabarelli B.S., Hellmer K. H. Der Einfluss von Metyrapon auf verschiedene Typen von mikrosomalen N-Oxidatione. Hoppe-Seyler's Z. Physiol. Chem. 1971; 352: 403
   PubMedGoogle Scholar
• Damani L., Patterson A.L. H., Gorrod J. W. Thin-layer chromatographic separation and identification of tertiary aromatic amines and their N-oxide. J. Chromatogr. 1978; 155: 337
   Web of Science ®Google Scholar
• Uehleke H., Stahn V. Zur biologischen Bildung von N.N-Dimethylanilin-N-Oxyd und N.N-Dimethylaminoazobenzol-N4-Oxyd aus den Aminen sowie ihre Reaktionen mit Hämoglobin und mit Lebermikrosome. Naunyn-Schmiedeberg's Arch. Pharmakol. Exp. Pathol. 1966; 255: 287
   Google Scholar
• Cowan D., Damani A.L. A., Gorrod J. W. Metabolic N-oxidation of 3-substituted pyridines: identification of products by mass spectrometr. Biomed. Mass Spectrom. 1978; 5: 551
   PubMedGoogle Scholar
• Miller J., Wyatt A., Miller C. S.E. C., Hartmann H. A. The N-hydroxylation of 4-acetylaminobiphenyl by the rat and dog and the strong carcinogenicity of N-hydroxy-4-acetylamino-biphenyl in the ra. Cancer Res. 1961; 21: 1465
   Web of Science ®Google Scholar
• Miller E., Miller C.J. A., Enomoto M. The comparative carcinogenicities of 2-acetylaminofluorene and its N-hydroxy metabolite in mice, hamsters, and guinea-pig. Cancer Res. 1969; 24: 2018
   Google Scholar
• Cramer J., Miller W.J. A., Miller E. C. N-Hydroxylation: a new metabolic reaction observed in the rat with the carcinogen 2-acetylaminofluoren. J. Biol. Chem. 1960; 235: 885
   PubMed Web of Science ®Google Scholar
• Sum C. V., Cho A. K. The metabolism of N-hydroxyphentermine by rat liver microsome. Drug Metab. Dispos. 1979; 7: 65
   PubMed Web of Science ®Google Scholar
• Radomski J. L., Brill E. The role of N-oxidation products of aromatic amines in the induction of bladder cancer in the do. Arch. Toxikol. 1971; 28: 159
   PubMedGoogle Scholar
• Wheeler L., Soderberg A.F. B., Goldman P. I. The reduction of N-hydroxy-4-acetylaminobiphenyl by the intestinal microflora of the ra. Cancer Res. 1975; 35: 2962
   PubMed Web of Science ®Google Scholar
• Lotlikar P., Wertman D.K., Luha L. Role of mixed-function amine oxidase in N-hydroxylation of 2-acetamidofluorene by hamster liver microsomal preparation. Biochem. J. 1973; 136: 1137
   PubMed Web of Science ®Google Scholar
• Gorrod J., Temple W.D. J., Beckett A. H. The metabolism of N-ethyl-N-methylaniline by rabbit liver microsomes: the measurement of metabolites by gas-liquid chromatograph. Xenobiotica 1975; 5: 453
   PubMed Web of Science ®Google Scholar
• Beckett A., Gorrod H.J. W., Jenner P. The analysis of nicotine-1′-N-oxide in urine, in the presence of nicotine and cotinine, and its application to the study of in vivo nicotine metabolism in ma. J. Pharm. Pharmacol. 1971; 23: 55 S
   Google Scholar
• Hawksworth G., Scheline R. R. Metabolism in the rat of some pyrazine derivatives having flavour importance in food. Xenobiotica 1975; 5: 389
   PubMed Web of Science ®Google Scholar
• Corbett M. D., Chipko B. R. Chloroperoxidase-catalysed oxidation of N-methyl-4-chioroanilin. Experientia 1979; 35: 1150
   PubMedGoogle Scholar
• Thorgeirsson S. S., Nelson W. L. Separation and quantitative determination of 2-acetylaminofluorene and its hydroxylated metabolities by high pressure liquid chromatograph. Anal. Biochem. 1976; 75: 122
   PubMed Web of Science ®Google Scholar
• Sternson L. A., Hincal F. Metabolic rearrangement of fluorenone oxime by rat liver homogenate. Biochem. Pharmacol. 1978; 27: 1919
   PubMed Web of Science ®Google Scholar
• Acara M., Camiolo S., Rennick B. Renal N-oxidation of trimethylamine in the chicken during tabular excretio. Drug Metab. Dispos. 1977; 5: 82
   PubMed Web of Science ®Google Scholar
• Stier A., Reitz I. Radical production in amine oxidation by liver microsome. Xenobiotica 1971; 1: 499
   PubMedGoogle Scholar
• Rosen G. M., Rauckman E. J. Formation and reduction of a nitroxide radical by liver microsome. Biochem. Pharmacol. 1977; 26: 675
   PubMed Web of Science ®Google Scholar
• Kimura T., Kodama M., Nagata C. Nitroxide radicals generated from carcinogenic aminoazo dyes during their metabolism in vivo and in enzymatic syste. in vitro, Biochem. Pharmacol. 1979; 28: 557
   PubMed Web of Science ®Google Scholar
• Floyd R. A., Soong L. M. Obligatory free radical intermediate in the oxidative activation of the carcinogen N-hydroxy-2-acetylaminofluoren. Biochim. Biophys. Acta 1977; 498: 244
   PubMed Web of Science ®Google Scholar
• Nelson W., Thorgeirsson L.S. S., Wirth P. J. Applications of the high performance liquid chromatographic techniques to metabolic problems of oxidation on nitrogen in organic molecule. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevier, Amsterdam 1978; 245
   Google Scholar
• Eyer P. Reactions of nitrosobenzene with reduced glutathion. Chem.-Biol. Interactions 1979; 24: 227
   PubMed Web of Science ®Google Scholar
• Smyth W. F., Smyth M. R. The polarographic behaviour and determination of some biologically important foreign N-containing organic compound. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevier, Amsterdam 1978; 281
   Google Scholar
• Neilands J. B. A crystalline organo-iron pigment from a rust fungus (Ustilago sphaerogena. J. Am. Chem. Soc. 1952; 74: 4846
   Web of Science ®Google Scholar
• Keller-Schierlein Mertens W., Prelog P.V., Walser A. Stoffwechselprodukte von Mikroorganismen. Die Ferrioxamine A1, A2 und D2. Helv. Chim. Acta 1965; 48: 710
   PubMed Web of Science ®Google Scholar
• Sayer J. M., Emery T. F. Structures of naturally occurring hydroxamic acids, fusarinines A and . Biochemistry 1968; 7: 184
   PubMed Web of Science ®Google Scholar
• Emery T. Hydroxamic acids of natural origi. Adv. Enzymol. 1971; 35: 135
   PubMedGoogle Scholar
• Snow G. A. The structure of mycobaction P. a growth factor for Mycobacterium johnei, and the signficance of its iron comple. Biochem. J. 1965; 94: 160
   PubMedGoogle Scholar
• Sigg H. P., Toth A. Über die Struktur der Phenazin-N-Oxid. Helv. Chim. Acta 1967; 50: 716
   PubMed Web of Science ®Google Scholar
• White E. C., Hill J. H. Studies on antibacterial products formed by molds. I. Aspergillic acid, a product of a strain o. Aspergillus flavus, J. Bacteriol. 1943; 45: 433
   PubMedGoogle Scholar
• Shigeura H. T., Gordon C. N. The mechanism of action of hadacidi. J. Biol. Chem. 1962; 237: 1937
   PubMedGoogle Scholar
• Clemo G. R., McIlwain H. The phenazine series. VII. The pigment of Chromobacterium iodinum; the phenazine di-N-oxide. J. Chem. Soc. (London) 1938; 479
   Google Scholar
• Bartz Q. R. Isolation and characterization of Chloromyceti. J. Biol. Chem. 1948; 172: 445
   PubMed Web of Science ®Google Scholar
• Phillipson J. D. Alkaloid N-oxide. Xenobiotica 1971; 1: 419
   PubMedGoogle Scholar
• Polonovski M., Nitzberg C. Etude sur les alcaloides de la feve de Calabar. II. La généserine nouvel alcaloide de la fev. Bull. Soc. Chim. Fr. 1915; 17: 244
   Google Scholar
• McLean E. K. The toxic actions of pyrrolizidine (Senecio) alkaloid. Pharmacol. Rev. 1970; 22: 429
   PubMedGoogle Scholar
• Tso T., Jeffrey R. N. Paper chromatography of alkaloids and their transformation products in Maryland tobacc. Arch. Biochem. Biophys. 1953; 43: 269
   PubMed Web of Science ®Google Scholar
• Craig J., Mary C., Goldman N. Y.N. L., Wolf L. Tertiary amine oxide rearrangements. III. The mechanism of the demethylation of nicotin. J. Am. Chem. Soc. 1964; 86: 3866
   Web of Science ®Google Scholar
• Wenkert E. The role of oxidation in the biogenesis of alkaloid. Experientia 1954; 10: 346
   PubMedGoogle Scholar
• Carter C. C., McChesney W. J. Hiptagenic acid identified as β-nitropropionic aci. Nature 1949; 164: 575
   PubMed Web of Science ®Google Scholar
• Poller P., Linneweh W. Über das Vorkommen von Trimethylaminoxyd in Clupea harengu. Ber. Dtsch. Chem. Ges. 1926; 59: 1362
   Google Scholar
• Norris E. R., Benoit G. J. Studies on trimethylamine oxide I. Occurrence of trimethylamine oxide in marine organism. J. Biol. Chem. 1945; 158: 433
   Web of Science ®Google Scholar
• Hoppe-Seyler F. A. Die bedingungen und die Bedeutung biologischer Methylierungsprozess. Z. Biol. 1930; 90: 433
   Google Scholar
• Dyer W. J. Trimethylamine oxide content of fish and marine invertebrate. J. Fish. Res. Board Can. 1952; 8: 314
   Google Scholar
• Lintzel W. Untersuchungen über Trimethylammoniumbasen. III. Trimethylammoniumbasen im menschlichen Har. Biochem. Z. 1934; 273: 243
   Google Scholar
• Cheymol Chabrier J., Dechezlepretre P.S., Bourillet F. Le trimèthylaminoxyde (TAMO). Données physico-chimiques, biologiques, physiologiques, pharmacologique. Biol. Méd. (Paris) 1967; 56: 124
   Google Scholar
• Hinsberg K., Gangl-Reuss E. Über die Trimethylamin- und Trimethylaminoxyd-Ausscheidung im Harn von Carcinomkranke. Z. Krebsforsch. 1941; 52: 227
   Google Scholar
• Caldwell J. Comparative aspects of the N-oxidation of aliphatic amines: studies with chlorphentermin. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevie, Amsterdam 1978; 57
   Google Scholar
• Renwick A. G., Williams R. T. The metabolites of cyclohexylamine in man and certain animal. Biochem. J. 1972; 129: 857
   PubMed Web of Science ®Google Scholar
• Belman Troll S., Teebor W.G., Mukai F. The carcinogenic and mutagenic properties of N-hydroxy-aminonaphthalene. Cancer Res. 1968; 28: 535
   PubMed Web of Science ®Google Scholar
• Enomoio Lotlikar M., Miller P.J. A., Miller E. C. Urinary metabolites of 2-acetylaminofluorene and related compounds in the rhesus monke. Cancer Res. 1962; 22: 1336
   Web of Science ®Google Scholar
• Miller J., Sato A., Poirier K.L. A., Miller E. C. Synthesis and formation in vivo of N-hydroxy-N-acetyl-p-aminoazo dye. Proc. Am. Assoc. Cancer Res. 1964; 5: 45
   Google Scholar
• Schulte K., Dreymann E. E., Möllmann H. Resorption, Verteilung in den Organen und Metabolisierung von Diäthylaminoäthanol nach oraler Applikation an Ratte. Drug Res. 1972; 22: 1381
   Google Scholar
• Dehner E., Machinist W.J. M., Ziegler D. M. Effect of SKF 525-A on the excretion of amine oxides by the ra. Life Sci. 1968; 7: 1135
   PubMed Web of Science ®Google Scholar
• Bickel M. H., Weder H. J. The total fate of a drug: kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramin. Arch. Int. Pharmacodyn. Thèr. 1968; 173: 433
   PubMedGoogle Scholar
• Posner H., Culpan S.R., Levine J. Quantification and probable structure, in human urine, of the non-phenolic and phenolic metabolites of chlorpromazin. J. Pharmacol. Exp. Ther. 1963; 141: 377
   PubMed Web of Science ®Google Scholar
• Hobbs D. C. Distribution and metabolism of doxepi. Biochem. Pharmacol. 1969; 18: 1941
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Kahn F. Metabolism, distribution and excretion of orphenadrin in ma. J. Pharm. Pharmacol. 1971; 23: 222 S
   Google Scholar
• Patton S., Rosen E., Rauckman G. M., Graham E. J.D. G., Small B., Ziegler D. M. Hampster hepatic nuclear mixed-function amine oxidase: location and specific activit. Mol. Pharmacol. 1980; 18: 151
   PubMed Web of Science ®Google Scholar
• Hathway D. E., Bedford C. T. Foreign Compound Metabolism in Mammals, D. E. Hathway. The Chemical Societ, London 1975; 3: 201
   Google Scholar
• Catanese B., Lisciani R., Silvestrini B. Urinary metabolites of benzydamine in rat. Drug Res. 1972; 22: 882
   Google Scholar
• Metzler M., Neumann H. G. Zur Bedeutung chemisch-biologischer Wechselwirkungen für die toxische und krebserzeugende Wirkung aromatischer Amine. IV. Stoffwechselmuster von trans-4-Dimethylaminostilben, cis-4-Dimethylaminostilben und Dimethylaminobibenzyl in Leber, Niere und den Ausscheidungsprodukten der Ratt. Z. Krebsforsch. 1971; 76: 16
   Google Scholar
• Damani L., Disley A.L. G., Gorrod J. W. The in vivo N-oxidation of 3-substituted pyridines following their intraperitoneal administratio. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevie, Amsterdam 1978; 157
   Google Scholar
• Neuhoff V., Köhler F. Biochemische Analyse des Stoffwechsels von 3-Acetylpyridin. Isolierung und Identifizierung von 6 Metabolite. Naunyn-Schmiedeberg's Arch. Pharmakol. Exp. Pathol. 1966; 254: 301
   Google Scholar
• Dagne E., Castagnoli N. Cotinine N-oxide, a new metabolite of nicotin. J. Med. Chem. 1972; 15: 840
   PubMed Web of Science ®Google Scholar
• Schwartz M., Postma A., Kolis E.S. J., Leon A. S. Metabolites of bromazepam, a benzodiazepine, in the human, dog, rat, and mous. J. Pharm. Sci. 1973; 62: 1776
   PubMed Web of Science ®Google Scholar
• Zins G., Emmert R.D. E., Walk R. A. Hypotensive metabolite production and sequential metabolism of N.N-diallylmelamine in rats, dogs and ma. J. Pharmacol. Exp. Ther. 1968; 159: 194
   PubMed Web of Science ®Google Scholar
• Boyland E., Nery R. Metabolism of arecoline and arecaidin. Biochem. J. 1969; 112: 33
   Web of Science ®Google Scholar
• Soudijn W., VanWijngaarden I. The metabolism and excretion of cinnarizine by rat. Life Sci. 1968; 7: 231
   PubMedGoogle Scholar
• Kuntzman Phillips R., Tsai A., Klutch I.A., Burns J. J. N-Oxide formation: a new route for inactivation of the antihistaminic chlorcyclizin. J. Pharmacol. Exp. Ther. 1967; 155: 337
   PubMed Web of Science ®Google Scholar
• Faulkner J. K., Smith K. J. A. Dealkylation and N-oxidation in the metabolism of 1-diethylcarbamyl-4-methylpiperazine in the ra. Xenobiotica 1972; 2: 59
   PubMed Web of Science ®Google Scholar
• McMartin C. The separation and detection of metabolites of guanethidin. Biochem. Pharmacol. 1969; 18: 238
   PubMed Web of Science ®Google Scholar
• Heimans R., Fennessy L. H.M. R., Gaff G. A. Some aspects of the metabolism of morphine-N-oxid. J. Pharm. Pharmacol. 1971; 23: 831
   PubMed Web of Science ®Google Scholar
• Oelschläger H., Möhrke W., Grein E. Metabolism of the new analgesic compound 3-(β-morpholinoethoxy)-1 H-indazole (O/Ma 35. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevier, Amsterdam 1978; 89
   Google Scholar
• Wilson K., Oram M., Reynolds C. N. N-Oxidation of methaqualone in healthy adults, geriatrics and patients with liver diseas. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevie, Amsterdam 1978; 145
   Google Scholar
• Breyer U. Urinary metabolites of 10-[3′-(4-methylpiperazinyl)-propyl] -phenothiazine (perazine) in psychiatric patients—I. Isolation, identification and determination of metabolite. Biochem. Pharmacol. 1969; 18: 777
   PubMed Web of Science ®Google Scholar
• Hinson J., Mitchell A.J. R., Jollow D. J. N-Hydroxylation of p-chloroacetanilide in hamster. Biochem. Pharmacol. 1976; 25: 599
   PubMed Web of Science ®Google Scholar
• Fries W., Kiese M., Lenk W. Oxidation of polycyclic N-arylacetamides to glycolamides and hydroxamic acids in rabbit. Xenobiotica 1973; 3: 525
   PubMed Web of Science ®Google Scholar
• Klutch A., Bordun M. Chromatographic methods for analysis of the metabolites of acetophenetidin (phenacetin. J. Pharm. Sci. 1968; 57: 524
   PubMed Web of Science ®Google Scholar
• Sato Poirier K., Miller L. A.J. A., Miller E. C. Studies on the N-hydroxylation and carcinogenicity of 4-aminoazobenzene and related compound. Cancer Res. 1966; 26: 1678
   PubMed Web of Science ®Google Scholar
• Parke D. V. Studies in detoxication. 84. The metabolism of [14C] aniline in the rabbit and other animal. Biochem. J. 1960; 77: 493
   PubMed Web of Science ®Google Scholar
• Dannenberg H., Kiese M. Nachweis von Nitrosobenzol in roten Zellen bei der Hämiglobinbildung durch Phenylhydroxylami. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. 1950; 211: 102
   PubMedGoogle Scholar
• Kiese M. Oxydation von Anilin zu Nitrosobenzol im Hund. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. 1959; 235: 354
   PubMedGoogle Scholar
• Irving C. C. On the structure of the glucuronide of N-hydroxy-2-acetylaminofluoren. J. Biol. Chem. 1965; 240: 1011
   PubMed Web of Science ®Google Scholar
• Radomski J., Rey L.A. A., Brill E. Evidence for a glucuronic acid conjugate of N-hydroxy-4-aminobiphenyl in the urine of dogs given 4-aminobipheny. Cancer Res. 1973; 33: 1284
   PubMed Web of Science ®Google Scholar
• Polonovski M., Nayrac P., Tiprez J. The N-oxide of morphine in therapeutic. Bull. Acad. Natl. Méd. Paris 1930; 103: 174
   Google Scholar
• Fennessy M. R. The analgesic action of morphine-N-oxid. Br. J. Pharmacol. 1968; 34: 337
   PubMed Web of Science ®Google Scholar
• Posner H., Hearst S., Taylor E.W. L., Cosmides G. J. Model metabolites of chlorpromazine and promazine: relative activities in some pharmacological and behavioural test. J. Pharmacol. Exp. Ther. 1962; 137: 84
   PubMed Web of Science ®Google Scholar
• Theobald Buech W., Kunz O.H. A., Morpurgo C. Zur Pharmakologie von Metaboliten des Imipramin. Med. Pharmacol. Exp. 1966; 15: 187
   PubMedGoogle Scholar
• Zins G., Emmert R.D. E., Walk R. A. The metabolism of diallylmelamine-N-oxid. Pharmacologist 1964; 6: 245
   Google Scholar
• Mamalis P. Some biological properties of amino-oxy compound. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevie, Amsterdam 1978; 399
   Google Scholar
• Irving C., Wiseman C.R., Hill J. T. Biliary excretion of the O-glucuronide of N-hydroxy-2-acetylaminofluorene by the rat and rabbi. Cancer Res. 1967; 27: 2309
   PubMed Web of Science ®Google Scholar
• Gutman H., Malejka-Giganti R., Barry D.E. J., Rydell R. E. On the correlation between hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by ra. Cancer Res. 1972; 32: 1554
   PubMed Web of Science ®Google Scholar
• Weisburger E., Grantham K.P. H., Weisburger J. H. Differences in the metabolism of N-hydroxy-N-2-fluorenylacetamide in male and female rat. Biochemistry 1964; 3: 808
   PubMed Web of Science ®Google Scholar
• Margreth Lotlikar A., Miller P. D.E. C., Miller J. A. The effects of hepatotoxic agents and of liver growth on the urinary excretion of the N-hydroxy metabolite of 2-acetyl-aminofluorene by rat. Cancer Res. 1964; 24: 920
   PubMedGoogle Scholar
• Baker J., Chaykin S. The biosynthesis of trimethylamine-N-oxid. Biochim. Biophys. Acta 1960; 41: 548
   PubMed Web of Science ®Google Scholar
• Willi P., Bickel M. H. Liver metabolic reactions: tertiary amine N-dealkylation, tertiary amine N-oxidation, N-oxide reduction, and N-oxide dealkylation. II. N,N-Dimethylanilin. Arch. Biochem. Biophys. 1973; 156: 772
   PubMed Web of Science ®Google Scholar
• Ziegler D. M., Pettit F. H. Microsomal Oxidases. I. The isolation and dialkylarylamine oxygenase activity of pork liver microsome. Biochemistry 1966; 5: 2932
   PubMed Web of Science ®Google Scholar
• Hill D., Laster L.W. R., Struck R. F. Enzymatic metabolism of cyclophosphamide and nicotine and production of a toxic cyclophosphamide metabolit. Cancer Res. 1972; 32: 658
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Belanger P. M. Metabolic incorporation of oxygen into primary and secondary aliphatic amines and the consequences in carbon-nitrogen cleavag. J. Pharm. Pharmacol. 1975; 27: 547
   PubMed Web of Science ®Google Scholar
• Mason H. S. Mechanisms of oxygen metabolis. Adv. Enzymol 1957; 19: 79
   PubMedGoogle Scholar
• Garfinkel D. Studies on pig liver microsomes. I. Enzymatic and pigment composition of different microsomal fraction. Arch. Biochem. Biophys. 1958; 77: 493
   PubMed Web of Science ®Google Scholar
• Klingenberg M. Pigments of rat liver microsome. Arch. Biochem. Biophys. 1958; 75: 376
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein natur. J. Biol. Chem. 1964; 239: 2370
   PubMed Web of Science ®Google Scholar
• Kawalek J. C., Lu A. Y. H. Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrate. Mol. Pharmacol. 1975; 11: 201
   PubMed Web of Science ®Google Scholar
• Haugen D. A., Coon M. J. Properties of electrophoretically homogeneous phenobarbital-inducible and β-naphthoflavone-inducible forms of liver microsomal cytochrome P-45. J. Biol. Chem. 1976; 251: 7929
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Separation and purification of multiple forms of microsomal cytochrome P-450. Activities of different forms of cytochrome P-450 toward several compounds of environmental interes. J. Biol. Chem. 1977; 252: 3970
   PubMed Web of Science ®Google Scholar
• Kamataki T.D., Belcher H., Neal R. H. Studies on the metabolism of diethyl p-nitrophenyl phosphorothionate (parathion) and benzphetamine using an apparently homogeneous preparation of rat liver cytochrome P-450: effect of a cytochrome P-450 antibody preparatio. Mol. Pharmacol. 1976; 12: 921
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Separation and purification of multiple forms of microsomal cytochrome P-450. Partial characterization of three apparently homogeneous cytochromes P-450 prepared from livers of phenobarbital- and 3-methylcholanthrene-treated rat. J. Biol. Chem. 1978; 253: 7931
   PubMed Web of Science ®Google Scholar
• Lu A. Y. H., West S. B. Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. III. Properties of the reconstituted 3, 4-benzpyrene hydroxylase syste. Mol. Pharmacol. 1972; 8: 490
   PubMed Web of Science ®Google Scholar
• Levin Lu W., Ryan A. Y. H., West D., Kuntzman S.R., Conney A. H. Partial purification and properties of cytochromes P-450 and P-448 from rat liver microsome. Arch. Biochem. Biophys. 1972; 153: 543
   PubMed Web of Science ®Google Scholar
• Lu A. Y. H., Levin W. The resolution and reconstruction of the liver microsomal hydroxylation syste. Biochim. Biophys. Acta 1974; 344: 205
   PubMed Web of Science ®Google Scholar
• Maines M. D., Anders M. W. Characterization of the heme of cytochrome P-450 using gas chromatography/mass spectrometr. Arch. Biochem. Biophys. 1973; 159: 201
   PubMed Web of Science ®Google Scholar
• Stern J. O., Peisach J. A model compound for nitrosyl cytochrome P-450; further evidence for mercaptide sulfur ligation to hem. FEBS Lett. 1976; 62: 364
   PubMed Web of Science ®Google Scholar
• Lu A. Y. H. Liver microsomal drug-metabolizing enzyme system: functional components and their propertie. Fed. Proc. 1976; 35: 2460
   PubMedGoogle Scholar
• Kulkarni A., Smith P.E., Hodgson E. Occurrence and characterization of microsomal cytochrome P-450 in several vertebrate and insect specie. Comp. Biochem. Physiol. 1976; 54B: 509
   Google Scholar
• Horecker B. L. Triphosphopyridine nucleotide-cytochrome c reductase in live. J. Biol. Chem. 1950; 183: 593
   Web of Science ®Google Scholar
• Iyanagi Anan T., Imai F. K.Y., Mason H. S. Studies on the microsomal mixed function oxidase system: redox properties of detergent-solubilized NADPH-cytochrome P-450 reductas. Biochemistry 1978; 17: 2224
   PubMed Web of Science ®Google Scholar
• Orrenius S.J., Ericson L. E., Ernster L. Phenobarbital-induced synthesis of the microsomal drug-metabolizing enzyme system and its relationship to the proliferation of endoplasmic membrane. J. Cell Biol. 1965; 25: 627
   PubMed Web of Science ®Google Scholar
• Remmer Schenkman H., Estabrook J., Sasame R. W., Gillette H., Narasimhulu J., Cooper S.D. Y., Rosenthal O. Drug interaction with hepatic microsomal cytochrom. Mol. Pharmacol. 1966; 2: 187
   PubMed Web of Science ®Google Scholar
• Schenkman J., Remmer B.H., Estabrook R. W. Spectral studies of drug interaction with hepatic microsomal cytochrom. Mol. Pharmacol. 1967; 3: 113
   PubMed Web of Science ®Google Scholar
• Jefcoate C., Gaylor R. E.J. L., Calabrese R. L. Ligand interactions with cytochrome P-450. I. Binding of primary amine. Biochemistry 1969; 8: 3455
   PubMed Web of Science ®Google Scholar
• Schenkman J. B. Studies on the nature of the type I and Type II spectral changes in liver microsome. Biochemistry 1970; 9: 2081
   PubMed Web of Science ®Google Scholar
• Temple D. J. Binding of nitrogen containing compounds to microsomal cytochrome. Xenobiotica 1971; 1: 507
   PubMedGoogle Scholar
• Hildebrandt Remmer A., Estabrook H.R. W. Cytochrome P-450 of liver microsomes - One pigment or man. Biochem. Biophys. Res. Commun. 1968; 30: 607
   PubMed Web of Science ®Google Scholar
• Peterson J., Ebel A.R., O'Keeffe D., Matsubara H.T., Estabrook R. W. Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase-cytochrome P-450 interactio. J. Biol. Chem. 1976; 251: 4010
   PubMed Web of Science ®Google Scholar
• Gigon P., Gram L.T. E., Gillette J. R. Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrate. Mol. Pharmacol. 1968; 5: 109
   Web of Science ®Google Scholar
• Estabrook R., Hildebrandt W., Baron A. G., Netter J.K. J., Leibman K. A new spectral intermediate associated with cytochrome P-450 function in liver microsome. Biochem. Biophys. Res. Commun. 1971; 42: 132
   PubMed Web of Science ®Google Scholar
• Cohen B. S., Estabrook R. W. Microsomal electron transport reaction. II. The use of reduced triphosphopyridine nucleotide and/or reduced diphosphopyridine nucleotide for the oxidative N-demethylation of aminopyrine and other drug substrate. Arch. Biochem. Biophys. 1971; 143: 46
   PubMed Web of Science ®Google Scholar
• Jansson I., Schenkman J. B. Influences of substrates of different microsomal electron transfer pathways on the oxidation-reduction kinetics of microsomal cytochrome b5. Arch. Biochem. Biophys. 1978; 185: 251
   PubMed Web of Science ®Google Scholar
• Hildebrandt A. G., Estabrook R. W. Evidence for the participation of cytochrome b5 in hepatic microsomal mixed-function oxidation reaction. Arch. Biochem. Biophys. 1971; 143: 66
   PubMed Web of Science ®Google Scholar
• Archakov A., Devichensky I.V. M., Karjakin A. V. Electron transfer in membranes of endoplasmic reticulum. Participation of cytochrome b5 in the NADPH oxidation reaction. The evidence for two cytochromes b5 in liver microsome. Arch. Biochem. Biophys. 1975; 166: 295
   PubMed Web of Science ®Google Scholar
• Estabrook R. W., Werringloer J. Active oxygen — fact or fanc. Microsomes and Drug Oxidations, V. Ullric hRoots, F. Hildebrandt, A. G.R. W. Estabrook, A. H. Conney. Pergamon Pres, Oxford 1977; 748
   Google Scholar
• O'Brien P. J. Hydroperoxides and superoxides in microsomal oxidation. Pharmacol. Ther. A 1978; 2: 517
   Web of Science ®Google Scholar
• Bock K. W., Remmer H. Induction of hepatic hemoprotein. Heme and Hemoproteins, F. De Matteis, W. N. Aldridge. Springer-Verla, Berlin 1978; 49
   Google Scholar
• Tephly T., Webb R., Trussler C., Kniffen P., Hasegawa F.E., Piper W. The regulation of heme synthesis related to drug metabolis. Drug Metab. Dispos. 1973; 1: 259
   PubMed Web of Science ®Google Scholar
• Estabrook R., Hildebrandt W., Remmer A. G., Schenkman H., Rosenthal J. B.O., Cooper D. Y. The role of cytochrome P-450 in microsomal mixed function oxidation reaction. Biochemie des Sauerstoffs, B. Hess, H. J. Staudinger. Springer-Verlag, Berlin 1968; 142
   Google Scholar
• Cooper D., Levine Y., Narasimhulu S., Rosenthal S.O., Estabrook R. W. Photochemical action spectrum of the terminal oxidase of mixed function system. Science 1965; 147: 400
   PubMed Web of Science ®Google Scholar
• Hildebrandt A. G. The binding of metyrapone to cytochrome P-450 and its inhibitory action on microsomal hepatic mixed-function oxidation reaction. Biological Hydroxylation Mechanisms, G. S. Boyd, R. M. S. Smellie. Academic Pres, London 1972; 79
   Google Scholar
• Franklin M. R. Inhibition of mixed-function oxidations by substrates forming reduced cytochrome P-450 metabolic-intermediate complexe. Pharmacol. Ther. A 1977; 2: 227
   Web of Science ®Google Scholar
• Leibman K. C., Ortiz E. Metyrapone and other modifiers of microsomal drug metabolis. Drug Metab. Dispos. 1973; 1: 184
   PubMed Web of Science ®Google Scholar
• Murakami K., Mason H. S. An electron spin resonance study of microsomal Fex. J. Biol. Chem. 1967; 242: 1102
   PubMed Web of Science ®Google Scholar
• Ichikawa Y., Yamano T. Reconversion of detergent- and sulfhydryl reagent-produced P-420 to P-450 by polyols and glutathion. Biochim. Biophys. Acta 1967; 131: 490
   PubMed Web of Science ®Google Scholar
• Levin Jacobson W., Sernatinger M.E., Kuntzman R. Breakdown of cytochrome P-450 heme by secobarbital and other allyl-containing barbiturate. Drug Metab. Dispos. 1973; 1: 275
   PubMed Web of Science ®Google Scholar
• Sato R., Omura T. Cytochrome P-450. Kodansha Ltd., Tokyo 1978
   Google Scholar
• Kampffmeyer H., Kiese M. The effect of carbon monoxide on the hydroxylation of aniline and N-ethylaniline by microsomal enzyme. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol 1965; 250: 1
   PubMedGoogle Scholar
• Appel Graffe W., Kampffmeyer W.H., Kiese M. Species differences in the hydroxylation of aniline and N-ethylaniline by liver microsome. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. 1965; 251: 88
   PubMedGoogle Scholar
• Tyler T., Buhs R. R. P., VandenHeuvel W. J. A. Identification of the mononitro derivative of dapsone as a product from an oxidatio. in vitro, Biochem. Pharmacol. 1973; 22: 1383
   PubMed Web of Science ®Google Scholar
• Uehleke H., Schnitger F., Hellmer K. H. Unterschiede der N-Hydroxylierung von 1- und 2-Naphthylami. Naunyn-Schmiedeberg's Arch. Pharmakol. 1970; 266: 470
   PubMedGoogle Scholar
• Franklin M. R. A new class of inhibitory cytochrome P-450 complexes formed during metabolism: a comparison with amphetamine and SKF 525-A type complexe. Chem.-Biol. Interact. 1976; 14: 337
   PubMed Web of Science ®Google Scholar
• Franklin M. R. The influence of cytochrome P-450 induction on the metabolic formation of 455-nm complexes from amphetamine. Drug Metab. Dispos. 1974; 2: 321
   PubMed Web of Science ®Google Scholar
• Jonsson J., Lindeke B. On the formation of cytochrome P-450 product complexes during the metabolism of phenylalkylamine. Acta Pharm. Suec. 1976; 13: 313
   PubMedGoogle Scholar
• Franklin M. R. The formation of a 455 nm complex during cytochrome P-450-dependent N-hydroxyamphetamine metabolis. Mol. Pharmacol. 1974; 10: 975
   Web of Science ®Google Scholar
• Mansuy Rouer D., Bacot E., Gans C., Chottard P.J., Leroux J. P. Interaction of aliphatic N-hydroxylamines with microsomal cytochrome P-450: nature of the different derived complexes and inhibitory effects on monoxygenases activitie. Biochem. Pharmacol. 1978; 27: 1229
   Web of Science ®Google Scholar
• Mansuy Gans D., Chottard P.J. C., Bartoli J. F. Nitrosoalkanes as Fe(II) ligands in the 455nm-absorbing cytochrome P-450 complexes formed from nitroalkanes in reducing condition. Eur. J. Biochem. 1977; 76: 607
   PubMedGoogle Scholar
• Mansuy Beaune D., Cresteil P., Bacot T., Chottard C.J., Gans P. Formation of complexes between microsomal cytochrome P-450-Fe(II) and nitrosoarenes obtained by oxidation of arylhy-droxylamines or reduction of nitroarene. in situ, Eur. J. Biochem. 1978; 86: 573
   PubMed Web of Science ®Google Scholar
• Nebert D. W. Genetic differences in microsomal electron transport: the Ah locu. Meth. Enzymol. 1978; 52: 226
   PubMedGoogle Scholar
• Nebert D. W. Genetic aspects of enzyme induction by drugs and chemical carcinogen. The Induction of Drug Metabolism, R. W. Estabrook, E. Lindenlaub. Schattauer Verla, Stuttgart 1979; 419
   Google Scholar
• Nelson S., Mitchell D., Timbrell J. R., Snodgrass J. A.W. R., Corcoran G. B. Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and ra. Science 1976; 193: 901
   PubMed Web of Science ®Google Scholar
• Gorrod J., Temple W.D. J., Beckett A. H. The differentiation of N-oxidation and N-dealkylation of N-ethyl-N-methylaniline by rabbit liver microsomes as distinct metabolic route. Xenobiotica 1975; 5: 465
   PubMed Web of Science ®Google Scholar
• Bickel M. H. The pharmacology and biochemistry of N-oxide. Pharmacol. Rev. 1969; 21: 325
   PubMed Web of Science ®Google Scholar
• Hildebrandt A., Leibman G.K. C., Estabrook R. W. Metyrapone interaction with hepatic microsomal cytochrome P-450 from rats treated with phenobarbita. Biochem. Biophys. Res. Commun. 1969; 37: 477
   PubMed Web of Science ®Google Scholar
• Hlavica P., Kehl M. Mechanism of N-oxide formation by hepatic mixed function oxidase. Microsomes and Drug Oxidations, V. Ullrich. Pergamon Pres, Oxford 1977; 346
   Google Scholar
• Hlavica P., Kehl M. Studies on the mechanism of hepatic microsomal N-oxide formation. The role of cytochrome P-450 and mixed-function amine oxidase in the N-oxidation of N.N-dimethylanilin. Biochem. J. 1977; 164: 487
   PubMed Web of Science ®Google Scholar
• Lu A., Somogyi Y. H., West A., Kuntzman S.R., Conney A. H. Pregnenolone-16α-carbonitrile: a new type of inducer of drug-metabolizing enzyme. Arch. Biochem. Biophys. 1972; 152: 457
   PubMed Web of Science ®Google Scholar
• Leakey J. E. A., Fouts J. R. Precocious development of cytochrome P-450 in neonatal rat liver after glucocorticoid treatmen. Biochem. J. 1979; 182: 233
   PubMed Web of Science ®Google Scholar
• Arrhenius A. Effects on hepatic microsomal N- and C-oxygenation of aromatic amines by in vivo corticosteroid or aminofluorene treatment, diet, or stres. Cancer Res. 1968; 28: 264
   PubMed Web of Science ®Google Scholar
• Devereux T. R., Fouts J. R. Effect of pregnancy of treatment with certain steroids on N.N-dimethylaniline demethylation and N-oxidation by rabbit liver or lung microsome. Drug Metab. Dispos. 1975; 3: 254
   PubMed Web of Science ®Google Scholar
• Gorrod J. W. On the multiplicity of microsomal N-oxidase system. Mechanisms of Oxidizing Enzymes, T. P. Singer, R. N. Ondarza. Elsevie, Amsterdam 1978; 189
   Google Scholar
• Hlavica P., Aichinger G. Spectral evidence for N- and C-oxidation of N.N-dimethylaniline by solubilized cytochrome P-450 from rabbit live. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevie, Amsterdam 1978; 195
   Google Scholar
• Hlavica P., Aichinger G. Studies on the cytochrome P-450 product complexes formed during the metabolism of N.N-dimethylanilin. Biochim. Biophys. Acta 1978; 544: 185
   PubMed Web of Science ®Google Scholar
• Sugiura Iwasaki M., Noguchi K.H., Kato R. Evidence for the involvement of cytochrome P-450 in tiaramide N-oxide reductio. Life Sci. 1974; 15: 1433
   PubMed Web of Science ®Google Scholar
• Hlavica P., Hülsmann S. Studies on the mechanism of hepatic microsomal N-oxide formation. N-Oxidation of N.N-dimethylaniline by a reconstituted rabbit liver microsomal cytochrome P-448 enzyme syste. Biochem. J. 1979; 182: 109
   PubMed Web of Science ®Google Scholar
• Mattocks A. R., White I. N. H. The conversion of pyrrolizidine alkaloids to N-oxides and to dihydropyrrolizine derivatives by rat-liver microsome. in vitro, Chem.-Biol. Interact. 1971; 3: 383
   PubMed Web of Science ®Google Scholar
• Hlavica P. On the nature of the 442-nm ferrohaemochrome formed during the oxidative metabolism of pyridine by the rabbit liver microsomal cytochrome P-450 syste. Proc. Int. Conference on Xenobiochemistry. Bratislava 1980; 35
   Google Scholar
• Hallström Lindeke G., Khuthier B.A. H., Al-Iraqi M. A. Microsomal formation and chemical decomposition of pargyline N-oxid. Chem. Biol. Interact. 1981; 34: 185
   PubMed Web of Science ®Google Scholar
• Pettit F., Orme-Johnson H.W., Ziegler D. M. The requirement for flavin adenine dinucleotide by liver microsomal oxygenase catalysing the oxidation of alkylaryl amine. Biochem. Biophys. Res. Commun. 1964; 16: 444
   PubMed Web of Science ®Google Scholar
• Ziegler D., Mitchell M.C. H., Jollow D. Properties of a purified hepatic microsomal mixed function amine oxidas. Microsomes and Drug Oxidations, J. R. Gillette Conney, A. H. Cosmides, G. J. Estabrook, R. W.J. R. Fouts, G. J. Mannering. Academic Pres, New York 1969; 173
   Google Scholar
• Ziegler D. M., Mitchell C. H. Microsomal oxidase IV: properties of a mixed-function amine oxidase isolated from pig liver microsome. Arch. Biochem. Biophys. 1972; 150: 116
   PubMed Web of Science ®Google Scholar
• Masters B. S. S., Ziegler D. M. The distinct nature and function of NADPH-cytochrome c reductase and the NADPH-dependent mixed-function amine oxidase from porcine liver microsome. Arch. Biochem. Biophys. 1971; 145: 358
   PubMed Web of Science ®Google Scholar
• Poulsen L. L., Ziegler D. M. The liver microsomal FAD-containing monooxygenase. Spectral characterization and kinetic studie. J. Biol. Chem. 1979; 254: 6449
   PubMed Web of Science ®Google Scholar
• Ziegler D. M., Poulsen L. L. Hepatic microsomal mixed-function amine oxidas. Meth. Enzymol. 1978; 52: 142
   PubMedGoogle Scholar
• Ziegler D., McKee M.E. M., Poulsen L. L. Microsomal flavoprotein-catalysed N-oxidation of arylamine. Drug Metab. Dispos. 1973; 1: 314
   PubMed Web of Science ®Google Scholar
• Ziegler D., Poulsen M.L. L., McKee E. M. Interaction of primary amines with a mixed-function amine oxidase isolated from pig liver microsome. Xenobiotica 1971; 1: 523
   PubMedGoogle Scholar
• Poulsen L., Hyslop L.R. M., Ziegler D. M. S-Oxidation of thioureylenes catalysed by a microsomal flavoprotein mixed-function oxidas. Biochem. Pharmacol. 1974; 23: 3431
   PubMed Web of Science ®Google Scholar
• Devereux T., Philpot R.R. M., Fouts J. R. The effect of Hg2+ on rabbit hepatic and pulmonary solubilized, partially purified N.N-dimethylaniline N-oxidase. Chem. Biol. Interact. 1977; 18: 277
   PubMed Web of Science ®Google Scholar
• Kitchell B., Rauckman S.E. J., Rosen G. M. The effect of temperature on mixed function amine oxidase intrinsic fluorescence and oxidation activit. Mol. Pharmacol. 1978; 14: 1092
   PubMed Web of Science ®Google Scholar
• Sofer S., Ziegler S.D. M., Popovich R. P. Synthesis of N-oxides with a hepatic microsomal drug oxidase insolubilized on artificial matrice. Biochem. Biophys. Res. Commun. 1974; 57: 183
   PubMed Web of Science ®Google Scholar
• Poulsen L., Kadlubar L.F. F., Ziegler D. M. Role of the microsomal mixed-function amine oxidase in the oxidation of N.N-disubstituted hydroxylamine. Arch. Biochem. Biophys. 1974; 164: 774
   PubMed Web of Science ®Google Scholar
• Rauckman E., Rosen J.G. M., Kitchell B. B. Superoxide radical as an intermediate in the oxidation of hydroxylamines by mixed function amine oxidas. Mol. Pharmacol. 1979; 15: 131
   PubMed Web of Science ®Google Scholar
• Poulsen L., Hyslop L.R. M., Ziegler D. M. S-Oxygenation of N-substituted thioureas catalysed by the pig liver microsomal FAD-containing monooxygenas. Arch. Biochem. Biophys. 1979; 198: 78
   PubMed Web of Science ®Google Scholar
• Ziegler D., Duffel M.M. W., Poulsen L. L. Studies on the nature and regulation of the cellular thiol: disulphide potentia. Sulphur in Biology. Elsevier, Amsterdam 1980; 191
   Google Scholar
• Gorrod J. W. Differentiation of various types of biological oxidation of nitrogen in organic compound. Chem.-Biol Interact. 1973; 7: 289
   Web of Science ®Google Scholar
• Gorrod J. W. The current status of the pK, concept in the differentiation of enzymic N-oxidatio. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevie, Amsterdam 1978; 201
   Google Scholar
• Böttcher G., Kiese M. Oxydation von Anilin zu Nitrosobenzol durch Peroxydase. Naturwissenschaften 1960; 47: 157
   Google Scholar
• Corbett M., Chipko D.B. R., Baden D. G. Chloroperoxidase-catalysed oxidation of 4-chloroaniline to 4-chloronitrosobenzen. Biochem. J. 1978; 175: 353
   PubMed Web of Science ®Google Scholar
• Hollenberg P. F., Hager L. P. P-450 nature of carbon monoxide complex of ferrous chloroperoxidas. J. Biol. Chem. 1973; 248: 2630
   PubMed Web of Science ®Google Scholar
• Kadlubar F., Morton F.K. C., Ziegler D. M. Microsomal-catalyzed hydroperoxide-dependent C-oxidation of amine. Biochem. Biophys. Res. Commun. 1973; 54: 1255
   PubMed Web of Science ®Google Scholar
• Møller B., Conn E. E. N-Hydroxyamino acids as intermediates in the biosynthesis of cyanogenic glucosides in plant. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevie, Amsterdam 1978; 437
   Google Scholar
• Kawai Kobayashi S., Oshima K.T., Egami F. Studies on the oxidation of p-aminobenzoate to p-nitrobenzoate b. Streptomyces thioluteus, Arch. Biochem. Biophys. 1965; 112: 537
   PubMed Web of Science ®Google Scholar
• Kaufman D., Plimmer D.J. R., Klingebiel U. I. Microbial oxidation of 4-chloroanilin. J. Agric. Food Chem. 1973; 21: 127
   PubMed Web of Science ®Google Scholar
• Large P. J. The oxidative cleavage of alkyl-nitrogen bonds in micro-organism. Xenobiotica 1971; 1: 457
   PubMedGoogle Scholar
• Channon H., Mills J.G. T., Williams R. T. The metabolism of 2,4,6-trinitrotoluen. Biochem. J. 1944; 38: 70
   PubMedGoogle Scholar
• Bray H., Hybs G., James Z.S. P., Thorpe W. V. Metabolism of 2,3,5,6- and 2.3.4.5-tetra-chloronitrobenzenes in the rabbit and the reduction of aromatic nitro compounds in the intestin. Biochem. J. 1953; 53: 266
   PubMed Web of Science ®Google Scholar
• Parke D. V. The metabolism of [14C] nitrobenzene in the rabbit and guinea pi. Biochem. J. 1956; 62: 339
   PubMed Web of Science ®Google Scholar
• Laham S. Biological conversion of 4-nitrobiphenyl to an active carcinoge. Can. J. Biochem. Physiol 1960; 38: 1383
   PubMedGoogle Scholar
• Westfall B. B. The reduction of 2,4,6-trinitrotoluene by animal tissue. in vitro, J. Pharmacol. Exp. Ther. 1943; 78: 386
   Google Scholar
• Parker V. H. Enzymic reduction of 2: 4-dinitrophenol by rat tissue homogenate. Biochem. J. 1952; 51: 363
   PubMed Web of Science ®Google Scholar
• Bueding E., Jolliffe N. Metabolism of trinitrotoluene (TNT. in vitro, J. Pharmacol. Exp. Ther. 1946; 88: 300
   PubMed Web of Science ®Google Scholar
• Uehleke H. Nitrosobenzol und Phenylhydroxylamin als Zwischenprodukte bei der biologischen Reduktion von Nitrobenzo. Naturwissenschaften 1963; 50: 335
   Web of Science ®Google Scholar
• Poirier L. A., Weisburger J. A. Enzymic reduction of carcinogenic aromatic nitro compounds by rat and mouse liver fraction. Biochem. Pharmacol. 1974; 23: 661
   PubMed Web of Science ®Google Scholar
• Morita M.D., Feller R., Gillette J. R. Reduction of niridazole by rat liver xanthine oxidas. Biochem. Pharmacol. 1971; 20: 217
   PubMed Web of Science ®Google Scholar
• Taylor J., Paul D.H. E., Paul M. F. Metabolism of nitrofurans III. Studies with xanthine oxidas. in vitro, J. Biol. Chem. 1951; 191: 223
   PubMed Web of Science ®Google Scholar
• Fouts J. R., Brodie B. B. The enzyrnic reduction of chloramphenicol, p-nitrobenzoic acid and other aromatic nitro compounds in mammal. J. Pharmacol. Exp. Ther. 1957; 119: 197
   PubMed Web of Science ®Google Scholar
• Carlson G. P., Du Bois K. P. Studies on the induction of nitroreductase activity by DDT and phenobarbita. Toxicol Appl. Pharmacol. 1970; 17: 203
   PubMed Web of Science ®Google Scholar
• Kato R., Oshima T., Takanaka A. Studies on the mechanism of nitro reduction by rat live. Mol. Pharmacol. 1969; 5: 487
   PubMed Web of Science ®Google Scholar
• Gillette J., Kamm R.J. J., Sasame H. A. Mechanism of p-nitrobenzoate reduction in liver: the possible role of cytochrome P-450 in liver microsome. Mol. Pharmacol. 1968; 4: 541
   PubMed Web of Science ®Google Scholar
• Sasame H. A., Gillette J. R. Studies on the relationship between the effects of various substances on adsorption spectrum of cytochrome P-450 and the reduction of p-nitrobenzoate by mouse liver microsome. Mol. Pharmacol. 1969; 5: 123
   PubMed Web of Science ®Google Scholar
• Feller D., Morita R.M., Gillette J. R. Enzymatic reduction of niridazole by rat liver microsome. Biochem. Pharmacol. 1971; 20: 203
   PubMed Web of Science ®Google Scholar
• Perez-Reyes E., Kalyanaraman B., Mason R. P. The reductive metabolism of metronidazole and ronidazole by aerobic liver microsome. Mol. Pharmacol. 1980; 17: 239
   PubMed Web of Science ®Google Scholar
• Peterson F., Mason J., Hovsepian R. P.J., Holtzman J. L. Oxygen-sensitive and -insensitive nitroreduction by Escherichia coli and rat hepatic microsome. J. Biol Chem. 1979; 254: 4009
   PubMed Web of Science ®Google Scholar
• Kato R., Takahashi A., Oshima T. Characteristics of nitro reduction of the carcinogenic agent, 4-nitroquinoline-N-oxid. Biochem. Pharmacol. 1970; 19: 45
   PubMed Web of Science ®Google Scholar
• Kiese M., Resag K., Schneider C. Reduktion von Nitrosobenzol durch Hämiglobinreduktase und durch altes gelbes Fermen. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. 1957; 231: 170
   PubMedGoogle Scholar
• Huennekens F., Caffrey M., Basford R. W.R. E., Gabrio B. W. Erythrocyte metabolism. IV. Isolation and properties of methemoglobin reductas. J. Biol Chem. 1957; 227: 261
   PubMed Web of Science ®Google Scholar
• Sum C. Y., Cho A. K. Properties of microsomal enzyme systems that reduce N-hydroxyphentermin. Drug Metab. Dispos. 1976; 4: 436
   PubMed Web of Science ®Google Scholar
• Kadlubar F., McKee F.E. M., Ziegler D. M. Reduced pyridine nucleotide-dependent N-hydroxy amine oxidase and reductase activities of hepatic microsome. Arch. Biochem. Biophys. 1973; 156: 46
   PubMed Web of Science ®Google Scholar
• Juchau M., Krasner R.J., Yaffe S. J. Model systems for aromatic nitro group reduction-Relationships to tissue catalysed reagent. Biochem. Pharmacol. 1970; 19: 443
   PubMedGoogle Scholar
• Bernheim M. L. C. The non-enzymic oxidation of NADH by nitrosobenzen. Biochem. Biophys. Res. Commun. 1972; 46: 1598
   PubMed Web of Science ®Google Scholar
• Zachariah P. K., Juchau M. R. The role of gut flora in the reduction of aromatic nitro group. Drug Metab. Dispos. 1974; 2: 74
   PubMed Web of Science ®Google Scholar
• Saz A. K., Slie R. B. The inhibition of organic nitro reductase by aureomycin in cell-free extracts. II. Cofactor requirements for the nitro reductase enzyme comple. Arch. Biochem. Biophys. 1954; 51: 5
   PubMed Web of Science ®Google Scholar
• Saz A. K., Slie R. B. Reversal of aureomycin inhibition of bacterial cell-free nitro reductase by manganes. J. Biol. Chem. 1954; 210: 407
   PubMed Web of Science ®Google Scholar
• Zucker M., Nason A. Nitroaryl reductase from Neurospora crass. Methods Enzymol. 1955; 2: 406
   Web of Science ®Google Scholar
• Higgins E. S. Reduction of nitroaryl groups b. Aspergillus niger. Fed. Proc. 1958; 17: 242
   Google Scholar
• Villanueva J. R. The purification of nitro-reductase fro. Nocardia, V. J. Biol Chem. 1964; 239: 773
   PubMed Web of Science ®Google Scholar
• Zucker M., Nason A. Hydroxylamine reductase fro. Neurospora crassa, Methods Enzymol. 1955; 2: 416
   Web of Science ®Google Scholar
• Ackermann D., Poller K., Linneweh W. Über das Verhalten des Trimethylaminoxyds im intermediären Stoffwechsel als biologischer Wasserstoff-Acceptor, besonders Sulfhydrylgruppen gegenübe. Z. Biol. 1927; 85: 435
   Google Scholar
• Coccia P. F., Westerfeld W. W. The metabolism of chlorpromazine by liver microsomal enzyme system. J. Pharmacol. Exp. Ther. 1967; 157: 446
   PubMed Web of Science ®Google Scholar
• Uehleke H., Stahn V. Oxydative Entmethylierung von Buttergelb und ribosomale Proteinsynthes. Naunyn-Schmiedeberg's Arch. Pharmak. Exp. Path. 1967; 257: 75
   PubMedGoogle Scholar
• Bickel M., Weder H.H. J., Aebi H. Metabolic interconversions between imipramine, its N-oxide, and its desmethyl derivative in rat tissue. in vitro, Biochem. Biophys. Res. Commun. 1968; 33: 1012
   PubMed Web of Science ®Google Scholar
• Sugiura M., Iwasaki K., Kato R. Reduction of tertiary amine N-oxides by liver microsomal cytochrome P-45. Mol. Pharmacol. 1976; 12: 322
   PubMed Web of Science ®Google Scholar
• Sugiura M., Iwasaki K., Kato R. Reduced nicotinamide adenine dinucleotide-dependent reduction of tertiary amine N-oxide by liver microsomal cytochrome P-45. Biochem. Pharmacol. 1977; 26: 489
   PubMed Web of Science ®Google Scholar
• Kato R., Iwasaki K., Noguchi H. Reduction of tertiary amine N-oxides by cytochrome P-450. Mechanism of the stimulatory effect of flavins and methyl viologe. Mol. Pharmacol. 1978; 14: 654
   PubMed Web of Science ®Google Scholar
• McMahon R. E., Sullivan H. R. Reduction of levopropoxyphene N-oxide to propoxyphene by dogs in vivo and rat liver microsomal fractio. in vitro, Xenobiotica 1977; 7: 377
   PubMed Web of Science ®Google Scholar
• Dajani R., Gorrod M.J. W., Beckett A. H. In vitro hepatic and extra-hepatic reduction of (-)-nicotine-l'-N-oxide in rat. Biochem. Pharmacol. 1975; 24: 109
   PubMed Web of Science ®Google Scholar
• Sugiura M., Iwasaki K., Noguchi H. Evidence for the involvement of cytochrome P-450 in tiaramide N-oxide reductio. Life Sci. 1974; 15: 1433
   PubMed Web of Science ®Google Scholar
• Powis G., Wincentsen L. Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-45. Biochem. Pharmacol. 1980; 29: 347
   PubMed Web of Science ®Google Scholar
• Iwasaki Noguchi K., Kato H., Imai R.Y., Sato R. Reduction of tertiary amine N-oxide by purified cytochrome P-45. Biochem. Biophys. Res. Commun. 1977; 77: 1143
   PubMed Web of Science ®Google Scholar
• Murray K. N., Chaykin S. The enzymatic reduction of nicotinamide N-oxid. J. Biol. Chem. 1966; 241: 2029
   PubMed Web of Science ®Google Scholar
• Murray K. N., Chaykin S. The reduction of nicotinamide N-oxide by xanthine oxidas. J. Biol. Chem. 1966; 241: 3468
   PubMed Web of Science ®Google Scholar
• Stöhrer G., Brown G. B. Purine N-oxides. XXVIII. The reduction of purine N-oxides by xanthine oxidas. J. Biol. Chem. 1969; 244: 2498
   PubMed Web of Science ®Google Scholar
• Brown G. B. Metabolic aspects of purine N-oxide derivative. Xenobiotica 1971; 1: 361
   PubMedGoogle Scholar
• Sugiura M., Kato R. Reduction of tertiary amine N-oxides by rat liver mitochondri. J. Pharmacol. Exp. Ther. 1977; 200: 25
   PubMed Web of Science ®Google Scholar
• Kiese M., Renner G., Schlaeger R. Mechanism of the autocatalytic formation of ferrihemoglobin by N.N-dimethylaniline-N-oxid. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. 1971; 268: 247
   Google Scholar
• Tatsumi H., Kanamitsu O. Biological activity of nicotinic acid N-oxide. IV. Reduction of nicotinic acid N-oxide by the resting cells of E. coli K 1. Yakugaku Zasshi 1961; 81: 1767
   PubMedGoogle Scholar
• May A. Bioreduction of pyridine-N-oxid. Enzymologia 1957; 18: 142
   PubMedGoogle Scholar
• Coutts R. T., Jones G. R. Metabolism in vitro of N-methylamphetamine and N-hydroxy-N-methylamphetamine with rat liver homogenate. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevier, Amsterdam 1978; 31
   Google Scholar
• Coutts R., Dawson T.G. W., Beckett A. H. In vitro metabolism of 1-phenyl-2-(n-propylamino) propane (N-propylamphetamine) by rat liver homogenate. J. Pharm. Pharmacol. 1976; 28: 815
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Bélanger P. M. The identification of three new metabolic products of phentermine after liver microsomal incubatio. Xenobiotica 1974; 4: 509
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Bélanger P. M. Metabolism of chlorphentermine and phentermine in man to yield hydroxylamino, C-nitroso- and nitro compound. J. Pharm. Pharmacol. 1974; 26: 205
   PubMed Web of Science ®Google Scholar
• Beckett A. H., Jones G. R. Metabolic oxidation of aralkyl oximes to nitro compounds by fortified 9000g liver supernatants from various specie. J. Pharm. Pharmacol. 1977; 29: 416
   PubMed Web of Science ®Google Scholar
• Coutts R., Dawe T., Dawson R.G. W., Kovach S. H. In vitro metabolism of 1-phenyl-2-propanone oxime in rat liver homogenate. Drug Metab. Dispos. 1976; 4: 35
   PubMed Web of Science ®Google Scholar
• Rauckman E., Rosen J., Kitcheli G. M. B. B., Moylan J. A. Oxidation of hydroxylamines to nitroxides by mixed function amine oxidas. Biological Oxidation of Nitrogen, J. W. Gorrod. Elsevier, Amsterdam 1978; 489
   Google Scholar
• Stier A., Reitz I., Sackmann E. Radical accumulation in liver microsomal membranes during biotransformation of aromatic amines and nitro compound. Naunyn-Schmiedeberg's Arch. Pharmacol. 1972; 274: 189
   Google Scholar
• Bartsch H., Hecker E. On the metabolic activation of the carcinogen N-hydroxy-N-2-acetyl-aminofluorene. III. Oxidation with horseradish peroxidase to yield 2-nitrosofluoreneand N-acetoxy-N-2-acetylaminofluoren. Biochim. Biophys. Acta 1971; 237: 567
   PubMed Web of Science ®Google Scholar
• Floyd R. A., Soong L. M. Obligatory free radical intermediate in the oxidative activation of the carcinogen N-hydroxy-2-acetylaminofluoren. Biochim. Biophys. Acta 1977; 498: 244
   PubMed Web of Science ®Google Scholar
• Rosen G. M., Rauckman E. J. Spin trapping of the primary radical involved in the activation of the carcinogen N-hydroxy-2-acetylaminofluorene by cumene hydroperoxidehemati. Mol. Pharmacol. 1980; 17: 233
   PubMed Web of Science ®Google Scholar
• Kiese M. Nitrogen oxidation in ferrihemoglobin formatio. Xenobiotica 1971; 1: 553
   PubMedGoogle Scholar
• Kiese M., Plattig K. H. Kreisprozess der Hämiglobinbildung durch Benzylphenylhydroxylamin und Benzalphenylnitro. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. 1958; 233: 484
   PubMedGoogle Scholar
• Machinist J., Orme-Johnson M.W. H., Ziegler D. M. Microsomal oxidases. II. Properties of a pork liver microsomal N-oxide dealkylas. Biochemistry 1966; 5: 2939
   PubMed Web of Science ®Google Scholar
• Pettit F., Ziegler D. M. The catalytic demethylation of N.N-dimethylaniline-N-oxide by liver microsome. Biochem. Biophys. Res. Commun. 1963; 13: 193
   Web of Science ®Google Scholar
• Fish M., Sweeley S., Johnson C. C., Lawrence N. M.E. P., Horning E. C. Chemical and enzymic rearrangements of N.N-dimethylamino acid oxide. Biochim. Biophys. Acta 1956; 21: 196
   PubMed Web of Science ®Google Scholar
• Machinist J., Dehner M.E. W., Ziegier D. M. Microsomal oxidases. III. Comparison of species and organ distribution of dialkylarylamine N-oxide dealkylase and dialkylarylamine N-oxidas. Arch. Biochem. Biophys. 1968; 125: 858
   PubMed Web of Science ®Google Scholar
• Barker E. A., Smuckler E. A. Altered microsomal function during acute thioacetamide poisonin. Mol. Pharmacol. 1972; 8: 318
   PubMed Web of Science ®Google Scholar
• Beije B., Hultin T. Oxidation and protein binding of aromatic amines by rat liver microsome. Chem. Biol. Interact. 1971; 3: 321
   PubMed Web of Science ®Google Scholar
• McMahon R. E., Sullivan H. R. The oxidative demethylation of 1-propoxyphene and 1-propoxyphene-N-oxide by rat liver microsome. Life Sci. 1964; 3: 1167
   PubMed Web of Science ®Google Scholar
• Terayama H. Aminoazo dye amine-N-oxide as a possible intermediate metabolite preceding N-demethylation and ortho-hydroxylation, as well as azo dye-protein bindin. Gann 1963; 54: 195
   PubMedGoogle Scholar
• Large P. J. Non-oxidative demethylation of trimethylamine N-oxide by Pseudomonas aminovoran. FEBS Lett. 1971; 18: 297
   PubMed Web of Science ®Google Scholar
• Myers P. A., Zatman L. J. The metabolism of trimethylamine N-oxide b. Bacillus PM 6, Biochem. J. 1970; 121: 10
   Web of Science ®Google Scholar
• Axeirod J. The enzymatic deamination of amphetamine (benzedrine. J. Biol Chem. 1955; 214: 753
   PubMedGoogle Scholar
• Hucker H. B. Phenylacetone oxime — an intermediate in amphetamine deaminatio. Drug Metab. Dispos. 1973; 1: 332
   PubMed Web of Science ®Google Scholar
• Corbett M., Chipko D.B. R., Batchelor A. O. The action of chloride peroxidase on 4-chloro-aniline. N-Oxidation and ring halogenatio. Biochem. J. 1980; 187: 893
   PubMed Web of Science ®Google Scholar
• Parli C. J., McMahon R. E. The mechanism of microsomal deamination: heavy isotope studie. Drug Metab. Dispos. 1973; 1: 337
   PubMed Web of Science ®Google Scholar
• Brodie B., Gillette B.J. R., LaDu B. N. Enzymatic metabolism of drugs and other foreign compound. Ann. Rev. Biochem. 1958; 27: 427
   PubMed Web of Science ®Google Scholar
• Miller E. C., Miller J. A. A mechanism of ortho-hydroxylation of aromatic amine. in vivo, Biochim. Biophys. Acta 1960; 40: 380
   PubMed Web of Science ®Google Scholar
• Heller H., Hughes E.E. D., Ingold C. K. A new view of the arylhydroxylamine rearrangemen. Nature 1951; 168: 909
   Web of Science ®Google Scholar
• Gutmann H. R., Erickson R. R. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro. An inducible enzymatic reactio. J. Biol. Chem. 1969; 244: 1729
   PubMed Web of Science ®Google Scholar
• Gutmann H. R., Erickson R. R. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro. Substrate specificity and mechanism of the reactio. J. Biol. Chem. 1972; 247: 660
   PubMed Web of Science ®Google Scholar
• Craig J., Dwyer C., Glazer F. P.A. N., Horning E. C. Tertiary amine oxide rearrangements. I. Mechanis. J. Am. Chem. Soc. 1961; 83: 1871
   Web of Science ®Google Scholar
• Bamberger E., Leyden P. Weitere Beiträge zur Kenntnis des Dimethylanilinoxyd. Ber. Dtsch. Chem. Ges. 1901; 34: 12
   Google Scholar
• Irving C. C. Metabolic activation of N-hydroxy compounds by conjugatio. Xenobiotica 1971; 1: 387
   PubMedGoogle Scholar
• Ide Green H., Kato S. K., Fishman W. H. Behaviour of the N-O-β-O-glucosiduronic acid of N-acetyl-N-phenylhydroxylamine as a substrate for β-glucuronidas. Biochem. J. 1968; 106: 431
   PubMed Web of Science ®Google Scholar
• Williams D., Grantham R., Marsh P. H., Weisburger H. H.J. H., Weisburger E. K. The participation of liver fractions and of intestinal bacteria in the metabolism of N-hydroxy-N-2-fluorenyl-acetamide in the ra. Biochem. Pharmacol. 1970; 19: 173
   PubMed Web of Science ®Google Scholar
• Miller E., Lotlikar C., Miller P. D., Butler J. A., Irving B. W.C. C., Hill J. T. Reactions in vitro of some tissue nucleophiles with the glucuronide of the carcinogen N-hydroxy-2-acetylamino-fluoren. Mol. Pharmacol. 1968; 4: 147
   PubMed Web of Science ®Google Scholar
• Weisburger J., Yamamoto A., Williams R. S., Grantham G. M., Matsushima P. H.T., Weisburger E. K. On the sulfate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the ra. Cancer Res. 1972; 32: 491
   PubMed Web of Science ®Google Scholar
• DeBaun J., Smith R., Miller J. Y. R.E. C., Miller J. A. Reactivity in vivo of the carcinogen N-hydroxy-2-acetylaminofluorene: increase by sulfate io. Science 1970; 167: 184
   PubMed Web of Science ®Google Scholar
• McDonald J. J., Stöhrer G., Brown G. B. Oncogenic purine N-oxide derivatives as substrates for sulfatas. Cancer Res. 1973; 33: 3319
   PubMed Web of Science ®Google Scholar
• Irving C., Janss C.D. H., Russell L. T. Lack of N-hydroxy-2-acetylaminofluorene sulfotransferase activity in the mammary gland and Zymbal's gland of the ra. Cancer Res. 1971; 31: 387
   PubMed Web of Science ®Google Scholar
• DeBaun J., Miller R.E. C., Miller J. A. N-Hydroxy-2-acetylaminofluorene sulfotransferase: its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat live. Cancer Res. 1970; 30: 577
   PubMed Web of Science ®Google Scholar
• Lotlikar P. D. Effects of sex hormones on enzymic esterification of 2-(N-hydroxy)acetamidofluorene by rat liver cytoso. Biochem. J. 1970; 120: 409
   PubMed Web of Science ®Google Scholar
• Andrews L., Pohl S., Hinson L. R., Fisk J. A.C. L., Gillette J. R. Production of a dimer of 2-acetylaminofluorene during the sulfation of N-hydroxy-2-acetylaminofluoren. in vitro. Drug Metab, Dispos. 1979; 7: 296
   PubMed Web of Science ®Google Scholar
• Lotlikar P. D., Luha L. Acetylation of the carcinogen N-hydroxy-2-acetylaminofluorene by acetyl coenzyme A to form a reactive este. Mol. Pharmacol. 1971; 7: 381
   PubMed Web of Science ®Google Scholar
• Lotlikar P. D., Luha L. Acylation of carcinogenic hydroxamic acids by carbamoyl phosphate to form reactive ester. Biochem. J. 1971; 124: 69
   PubMed Web of Science ®Google Scholar
• Bartsch Dworkin H., Miller M.J. A., Miller E. C. Electrophilic N-acetoxyaminoarenes derived from carcinogenic N-hydroxy-2-acetylaminoarenes by enzymic deacetylation and transacetylation in live. Biochim. Biophys. Acta 1972; 286: 272
   PubMed Web of Science ®Google Scholar
• Bartsch Dworkin H., Miller C.E. C., Miller J. A. Formation of electrophilic N-acetoxy arylamines in cytosol from rat mammary gland and other tissues by transacetylation from the carcinogen N-hydroxy-4-acetylaminobipheny. Biochim. Biophys. Acta 1973; 304: 42
   PubMed Web of Science ®Google Scholar
• Bartsch H., Traut M., Hecker E. On the metabolic activation of N-hydroxy-N-2-acetylamino-fluorene. II. Simultaneous formation of 2-nitrosofluorene and N-acetoxy-N-2-acetylaminofluorene from N-hydroxy-N-2-acetylaminofluorene via a free radical intermediat. Biochim. Biophys. Acta 1971; 237: 556
   PubMed Web of Science ®Google Scholar
• Kriek Miller E., Juhl J. A.U., Miller E. C. 8-(N-2-Fluorenylacetamido)guanosine, an aryl-amidation reaction product of guanosine and the carcinogen N-acetoxy-N-2-fluorenylacetamide in neutral solutio. Biochemistry 1967; 6: 177
   PubMed Web of Science ®Google Scholar
• Kriek E. Carcinogenesis by aromatic amine. Biochim. Biophys. Acta 1974; 355: 177
   PubMed Web of Science ®Google Scholar
• Cottam G., Kupiecki L.F. P., Coon M. J. A study of the mechanism of O-phosphorylhydroxylamine synthesis catalyzed by pyruvate kinas. J. Biol Chem. 1968; 243: 1630
   PubMed Web of Science ®Google Scholar
• King C. M., Phillips B. N-Hydroxy-2-fluorenylacetamide. Reaction of the carcinogen with guanosine, ribonucleic acid, deoxyribonucleic acid, and protein following enzymatic deacetylation or esterificatio. J. Biol. Chem. 1969; 244: 6209
   PubMed Web of Science ®Google Scholar
• Lotlikar P. D. Enzymatic N-O-methylation of hydroxamic acid. Biochim. Biophys. Acta 1968; 170: 468
   PubMed Web of Science ®Google Scholar
• Weisburger J., Grantham H.P. H., Weisburger E. K. The metabolism of N-2-fluorenylhy-droxylamine in male and female rat. Biochem. Pharmacol. 1966; 15: 833
   Web of Science ®Google Scholar
• Lotlikar P. D., Luha L. Enzymic N-acetylation of N-hydroxy-2-aminofluorene by liver cytosol from various specie. Biochem. J. 1971; 123: 287
   PubMed Web of Science ®Google Scholar
• Grantham P., Weisburger H.E. K., Weisburger J. H. Dehydroxylation and deacetylation of N-hydroxy-N-2-fluorenylacetamide by rat liver and brain homogenate. Biochim. Biophys. Acta 1965; 107: 414
   PubMed Web of Science ®Google Scholar
• Irving C. C. Enzymatic deacetylation of N-hydroxy-2-acetylaminofluorene by liver microsome. Cancer Res. 1966; 26: 1390
   PubMed Web of Science ®Google Scholar
• Järvinen M.R., Santti S. S., Hopsu-Havu V. K. Partial purification and characterization of two enzymes from guinea-pig liver microsomes that hydrolyze carcinogenic amides 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluoren. Biochem. Pharmacol. 1971; 20: 2971
   PubMed Web of Science ®Google Scholar
• Hinson J., Nelson A.S. D., Mitchell J. R. Studies on the microsomal formation of arylating metabolites of acetaminophen and phenaceti. Mol. Pharmacol. 1977; 13: 625
   PubMed Web of Science ®Google Scholar
• Corbett M. D., Chipko B. R. N-Phenylglycolhydroxamate production by the action of transke-tolase on nitrosobenzen. Biochem. J. 1977; 165: 263
   PubMed Web of Science ®Google Scholar
• Corbett M., Baden D.D. G., Chipko B. R. The nonmicrosomal production of N-(4-chloro-phenyl)-glycolhydroxamic acid from 4-chloronitrosobenzene by rat liver homogenate. Bioorg. Chem. 1979; 8: 227
   Web of Science ®Google Scholar
• Hamer J., Macaluso A. Nitrone. Chem. Rev. 1964; 64: 473
   Web of Science ®Google Scholar
• Beckett A., Navas H., Hutt G. E.A. J., Farag M. Disappearing N-hydroxy compound. J. Pharm. Pharmacol. 1979; 31: 476
   PubMed Web of Science ®Google Scholar
• Kiese M. Methemoglobinemia: A Comprehensive Treatise. CRC Pres, Cleveland 1974
   Google Scholar
• Uehleke H. Toxikologische Aspekte der N-Hydroxylierung aromatischer Amin. Naunyn-Schmiedeberg's Arch. Pharmakol. Exp. Pathol. 1969; 263: 106
   Google Scholar
• Suwa A. Untersuchungen über die Organextrakte der Selachier. I. Die Muskelextraktstoffe des Dornhaie. Arch. Ges. Physiol 1909; 128: 421
   Google Scholar
• Heubner W. Studien über Methämoglobinbildung. Dritte Mitteilung über den Zusammenhang zwischen chemischer Konstitution und Wirkun. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmakol. 1913; 72: 241
   Google Scholar
• Ellinger P. Über den Mechanismus der Methämoglobinbildung durch Acetanilid und seine Abkömmling. Hoppe-Seyler's Z. Physiol. Chem. 1920; 111: 86
   Google Scholar
• Weisburger J. H., Weisburger E. K. Biochemical formation and pharmacological, toxicological, and pathological properties of hydroxylamines and hydroxamic acid. Pharmacol. Rev. 1973; 25: 1
   PubMed Web of Science ®Google Scholar
• Kuwada M., Horie S., Ogura Y. Studies on the enzymatic reduction of C-nitroso compounds. II. Multiple forms of liver C-nitrosoreductase and the identity with alcohol dehydrogenas. J. Biochem. (Tokyo) 1980; 88: 859
   PubMed Web of Science ®Google Scholar
• Horie S., Ogura Y. Studies on the enzymatic reduction of C-nitroso compounds. IV. Partial purification and kinetic properties of porcine heart C-nitrosoreductas. J. Biochem. (Tokyo) 1980; 88: 1141
   PubMed Web of Science ®Google Scholar
• McMahon R., Turner E.J. C., Whitaker G. W. The N-hydroxylation and ring-hydroxylation of 4-aminobiphenyl in vitro by hepatic mono-oxygenases from rat, mouse, hamster, rabbit and guinea-pi. Xenobiotica 1980; 10: 469
   PubMed Web of Science ®Google Scholar
• Blaauboer B. J., Paine A. J. Reversed phase high-performance liquid chromatography of heterocyclic aromatic N-oxides: application to measurement of N-oxidation by microsomes and rat hepatocytes in primary cultur. Xenobiotica 1980; 10: 655
   PubMed Web of Science ®Google Scholar
• Stier A., Clauss R., Lücke A., Reitz I. Redox cycle of stable mixed nitroxides formed from carcinogenic aromatic amine. Xenobiotica 1980; 10: 661
   PubMed Web of Science ®Google Scholar
• Köchli H., Wermuth W.B., Wartburg J. P. Characterization of a mitochondrial NADH-dependent nitro reductase from rat brai. Biochim. Biophys. Acta 1980; 616: 133
   PubMed Web of Science ®Google Scholar